TwinBeech Capital’s Medifast MED Stock Holding History

TwinBeech Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46,501	Closed	-$1.01M	–	800
2024 Q2	$1.01M	Buy	46,501 +21,172	+84%	+$564K	0.02%	404
2024 Q1	$971K	Buy	+25,329	New	+$1.23M	0.02%	425
2023 Q1	–	Sell	-32,720	Closed	-$3.77M	–	781
2022 Q4	$3.77M	Buy	32,720 +10,318	+46%	+$1.2M	0.07%	321
2022 Q3	$2.43M	Buy	+22,402	New	+$3.21M	0.06%	306
2022 Q2	–	Sell	-4,764	Closed	-$814K	–	635
2022 Q1	$814K	Buy	4,764 +253	+6%	+$47.7K	0.04%	344
2021 Q4	$945K	Sell	4,511 -13,245	-75%	-$2.74M	0.05%	354
2021 Q3	$3.42M	Buy	17,756 +9,271	+109%	+$2.28M	0.24%	124
2021 Q2	$2.4M	Sell	8,485 -341	-4%	-$92.4K	0.29%	110
2021 Q1	$1.87M	Buy	+8,826	New	+$2.11M	0.27%	119
2020 Q4	–	Sell	-1,775	Closed	-$292K	–	547
2020 Q3	$292K	Buy	+1,775	New	+$292K	0.06%	346

Other funds holding MED

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TwinBeech Capital's MED Position: Q3 2024 in Review

TwinBeech Capital sold out of Medifast (MED) in Q3 2024, closing a stake of 46,501 shares — an estimated $1.01M sold.

TwinBeech Capital first reported a position in MED in Q3 2020 and held it in 10 quarters. The position peaked at $3.77M in Q4 2022. 140 funds tracked by Wall St. Rank hold MED as of Q3 2024.

TwinBeech Capital reported no remaining Medifast position as of Q3 2024 after selling out during the quarter.
TwinBeech Capital sold 46,501 Medifast shares in Q3 2024, an estimated $1.01M.
TwinBeech Capital first reported a position in Medifast in Q3 2020 and held it in 10 quarters.
TwinBeech Capital's Medifast position peaked at $3.77M in Q4 2022.
140 funds tracked by Wall St. Rank held Medifast as of Q3 2024.

Based on TwinBeech Capital's 13F filing for Q3 2024, filed 14 Nov 2024.